Hematopoietic stem cell mobilizing agents G-CSF, cyclophosphamide or AMD3100 have distinct mechanisms of action on bone marrow HSC niches and bone formation
IG Winkler, AR Pettit, LJ Raggatt, RN Jacobsen, CE Forristal, V Barbier, B Nowlan, A Cisterne, LJ Bendall, NA Sims, J-P Levesque
Leukemia | NATURE PUBLISHING GROUP | Published : 2012
Awarded by National Health and Medical Research Council (NHMRC)
During the course of this study, JPL was supported by a Senior Research Fellowship from the Cancer Council Queensland, IGW, LJB, and ARP by Career Development Award fellowships and NAS by a Senior Research Fellowship from the National Health and Medical Research Council (NHMRC #488817, #511965, #519744 and #345401, respectively), RNJ by an Australian Post-Graduate Award. This work was supported by NHMRC Project Grants #434515 to JPL and IGW, #345401 to LJR and ARP, and an Anthony Rothe Grant to LJB.